beta

EVO

Evotec SE

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists.

Market Cap: 2.51 Billion

Primary Exchange: NASDAQ

Website: https://www.evotec.com/

Shares Outstanding: 354 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 1.4966788149483237

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Bond Type: MUNI

Ethical Flags

Longest drawdown: 1513 trading days

From: 2013-01-04 To: 2019-01-18

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2019-01-11 2019-01-22 2019-01-14 2019-01-02 0.0722 Cash
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud